High Molecular Weight Kininogen Regulates Prekallikrein Assembly and Activation on Endothelial Cells: A Novel Mechanism for Contact Activation
Open Access
- 15 January 1998
- journal article
- Published by American Society of Hematology in Blood
- Vol. 91 (2) , 516-528
- https://doi.org/10.1182/blood.v91.2.516
Abstract
The consequences of assembling the contact system of proteins on the surface of vascular cells has received little study. We asked whether assembly of these proteins on the surface of cultured human endothelial cells (HUVECs) results in the activation of prekallikrein (PK) and its dependent pathways. Biotinylated PK binds specifically and reversibly to HUVECs in the presence of high molecular weight kininogen (HK) (apparent Kd of 23 ± 11 nmol/L,Bmax of 1.7 ± 0.5 × 107 sites per cell [mean ± SD, n = 5 experiments]). Cell-associated PK is rapidly converted to kallikrein. Surprisingly, the activation of cell-associated HK•PK complexes is entirely independent of exogenous factor XII (Km = 30 nmol/L,Vmax = 12 ± 3 pmol/L/min in the absencevKm = 20 nmol/L,Vmax = 9.2 ± 2.1 pmol/L/min in the presence of factor XII). Rather, kallikrein formation is mediated by an endothelial cell-associated, thiol protease. Cell-associated HK is proteolyzed during the course of prekallikrein activation, releasing kallikrein from the surface. Furthermore, activation of PK bound to HK on HUVECs promotes kallikrein-dependent activation of pro-urokinase, resulting in the formation of plasmin. These results indicate the existence of a previously undescribed, factor XII-independent pathway for contact factor activation on HUVECs that regulates the production of bradykinin and may contribute to cell-associated plasminogen activation in vivo.Keywords
This publication has 59 references indexed in Scilit:
- Activation of plasminogen by human plasma kallikreinPublished by Elsevier ,2004
- Pro‐urokinase and prekallikrein are both associated with plateletsFEBS Letters, 1993
- Factor XII clotting activity and antigen levels in patients with thromboembolic diseaseBlood Coagulation & Fibrinolysis, 1992
- Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo.Journal of Clinical Investigation, 1991
- Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: A randomized placebo-controlled studyJournal of the American College of Cardiology, 1991
- Thrombosis or Myocardial Infarction in Congenital Clotting Factor Abnormalities and Chronic ThrombocytopeniasMedicine, 1983
- A comparision of the abilities of plasma kallikrein, β-factor XIIa, factor XIa and urokinase to activate plasminogenThrombosis Research, 1983
- Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogenBlood, 1979
- The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.Journal of Clinical Investigation, 1978
- Rôle du Facteur Contact (Facteur Hageman) dans la FibrinolyseThrombosis and Haemostasis, 1959